A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Conditions: Rheumatoid Arthritis (RA); Psoriatic Arthritis (PsA) Intervention: Sponsor: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
